MedTrace Logo

Efficacy of Moxibustion in Diabetes Peripheral Neuropathy

NCT04894461 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-05-20

No results posted yet for this study

Summary

This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on diabetes peripheral neuropathy.

Conditions

Interventions

DEVICE

Moxibustion

The moxibustion treatment sessions are three times per week for eight weeks. Indirect moxa stick will be used.

Sponsors & Collaborators

  • Xiamen University

    lead OTHER

Principal Investigators

  • Linchao Qian, BMed · Xiamen University Malaysia

  • Muhammad Shahzad Aslam, Ph.D · Xiamen University Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-09-30
Completion
2023-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04894461 on ClinicalTrials.gov